Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1991-04-09
1992-03-03
Maples, John S.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
252625, A61K 4902
Patent
active
050931059
ABSTRACT:
Benzalkonium chloride and benzethonium chloride are each useful in radiopharmaceutical preparations as bacteriostatic agents which are compatible with anti-oxidants.
REFERENCES:
Abdullah, M. J. and Said, S. A., Drug Res., 31 (I), Nr. 1 (1981), pp. 59-61.
Richards, R. M. E. and McBride, R. J., J. Pharm. Pharmac. 24, 145-148, (1972).
Kurtz, L. D. (I), Chemical Abstracts, 76, 103785 h (1972).
Kurtz, L. D. (II), Chemical Abstracts, 76, 10378k (1972).
Remington's Pharmaceutical Sciences, 18th ed., Philadelphia College of Pharm. Sci., (1990) p.1164.
Remington's Pharmaceutical Sciences, 18th ed., Philadelphia Collge of Pharm. Sci. (1990), p. 1170.
Flanagan Richard J.
Tartaglia Daniel
DiPrima Joseph F.
Maples John S.
Merck Frosst Canada Inc.
Nicholson William H.
Thies J. Eric
LandOfFree
Radiopharmaceutical bacteriostats does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radiopharmaceutical bacteriostats, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radiopharmaceutical bacteriostats will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-270847